Mass General Brigham Ventures

Mass General Brigham Ventures (MGBV) operates as the strategic venture capital arm of Mass General Brigham, a leading integrated academic healthcare system based in Cambridge, Massachusetts. Leveraging the extensive clinical and research capabilities of its parent organization, including renowned institutions like Massachusetts General Hospital and Brigham and Women's Hospital, MGBV focuses on investing in early-stage life science and healthcare companies. Their investment thesis is deeply rooted in identifying innovations that can address unmet medical needs and improve patient care, often originating from or aligning with the research priorities within the Mass General Brigham ecosystem.

MGBV's investment scope spans a broad spectrum of healthcare innovation, encompassing therapeutics, medical devices, diagnostics, digital health, and healthcare IT. Beyond providing capital, the firm distinguishes itself by offering portfolio companies unparalleled access to clinical expertise, research infrastructure, and strategic guidance from within the Mass General Brigham network. This unique value proposition allows MGBV to not only provide financial backing but also to accelerate the development and validation of promising technologies through clinical collaboration and real-world application.

Since its inception, Mass General Brigham Ventures has demonstrated a robust investment pace, having invested in over 60 companies. Their typical initial check sizes range from $1 million to $5 million, often participating in Series A and Series B rounds alongside other prominent venture capital firms. This strategic approach underscores their commitment to fostering innovation that can be integrated into or benefit from a large-scale healthcare system, aiming to drive both financial returns and significant advancements in patient health.